bismuth has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apostolidis, C; Bacher, K; de Gelder, V; De Vos, F; Dierckx, RA; Lahorte, C; Molinet, R; Nikula, TK; Offner, F; Philippé, J; Slegers, G; Thierens, H; Vandenbulcke, K; Vral, A | 1 |
Apostolidis, C; Bacher, K; de Gelder, V; De Vos, F; Dierckx, RA; Janssens, A; Morgenstern, A; Offner, F; Philippé, J; Slegers, G; Thierens, H; Vandenbulcke, K | 1 |
Campbell, DR; Cherian, R; McGregor, DH; Weston, AP | 1 |
1 review(s) available for bismuth and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms | 1994 |
2 other study(ies) available for bismuth and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Apoptosis; Bismuth; Chromosome Aberrations; Chromosomes; Dose-Response Relationship, Radiation; Female; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Models, Biological; Radiation Dosage; Radioisotopes; Reference Values; Relative Biological Effectiveness; Rituximab; Treatment Outcome | 2003 |
In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia.
Topics: Alpha Particles; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bismuth; Combined Modality Therapy; Drug Synergism; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Energy Transfer; Radioisotopes | 2006 |